Björnsson Einar
Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Med pol II, SE-413 45 Gothenburg, Sweden.
Curr Gastroenterol Rep. 2009 Feb;11(1):37-41. doi: 10.1007/s11894-009-0006-6.
Patients with cholestatic liver tests and typical histologic features of primary sclerosing cholangitis (PSC) but a normal cholangiogram have been identified as having small-duct PSC. This subgroup of PSC has been less well characterized than the classic large-duct form. Some patients characterized as having small-duct PSC develop cholangiographic features of PSC during follow-up. Three papers published in 2002 on small-duct PSC patients suggested a better prognosis in patients with small-duct PSC than in those with large-duct PSC. However, these studies included a limited number of patients and had a short follow-up. A combined cohort of these patients with a prolonged follow-up recently confirmed these previous observations. However, some patients will suffer from liver-related mortality or will need to undergo liver transplantation. Recurrence of small-duct PSC after liver transplantation has been reported. Cholangiocarcinoma, the most feared complication of PSC, has not been described in a patient with small-duct PSC without progression first to large-duct PSC.
肝生化检查提示胆汁淤积且具有原发性硬化性胆管炎(PSC)典型组织学特征,但胆管造影正常的患者被诊断为小胆管PSC。与典型的大胆管型PSC相比,该亚组PSC的特征尚未得到充分描述。一些被诊断为小胆管PSC的患者在随访过程中出现了PSC的胆管造影特征。2002年发表的三篇关于小胆管PSC患者的论文表明,小胆管PSC患者的预后优于大胆管PSC患者。然而,这些研究纳入的患者数量有限且随访时间较短。最近,对这些患者进行的一项延长随访的联合队列研究证实了之前的观察结果。然而,一些患者将死于肝脏相关疾病或需要接受肝移植。肝移植后小胆管PSC复发的情况已有报道。PSC最可怕的并发症胆管癌,在未先进展为大胆管PSC的小胆管PSC患者中尚未见报道。